These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27131877)

  • 1. Refolded Recombinant Human Paraoxonase 1 Variant Exhibits Prophylactic Activity Against Organophosphate Poisoning.
    Bajaj P; Tripathy RK; Aggarwal G; Datusalia AK; Sharma SS; Pande AH
    Appl Biochem Biotechnol; 2016 Sep; 180(1):165-76. PubMed ID: 27131877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli.
    Bajaj P; Tripathy RK; Aggarwal G; Pande AH
    Protein Expr Purif; 2015 Nov; 115():95-101. PubMed ID: 26003526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives.
    Bajaj P; Tripathy RK; Aggarwal G; Pande AH
    ScientificWorldJournal; 2014; 2014():854391. PubMed ID: 25386619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards Understanding the Catalytic Mechanism of Human Paraoxonase 1: Experimental and In Silico Mutagenesis Studies.
    Tripathy RK; Aggarwal G; Bajaj P; Kathuria D; Bharatam PV; Pande AH
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1642-1662. PubMed ID: 28161867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme.
    Bajaj P; Tripathy RK; Aggarwal G; Pande AH
    Protein Sci; 2013 Dec; 22(12):1799-807. PubMed ID: 24123308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fused human paraoxonase 1 as a prophylactic agent against organophosphate poisoning.
    Dobariya P; Adhya P; Vaidya B; Khandave PY; Sharma SS; Pande AH
    Enzyme Microb Technol; 2023 Apr; 165():110209. PubMed ID: 36764031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
    Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
    Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate.
    Sunay SZ; Kayaaltı Z; Bayrak T; Söylemezoğlu T
    Toxicol Ind Health; 2015 Dec; 31(12):1061-8. PubMed ID: 23625910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning.
    Stevens RC; Suzuki SM; Cole TB; Park SS; Richter RJ; Furlong CE
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12780-4. PubMed ID: 18711144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes.
    Gaidukov L; Bar D; Yacobson S; Naftali E; Kaufman O; Tabakman R; Tawfik DS; Levy-Nissenbaum E
    BMC Clin Pharmacol; 2009 Nov; 9():18. PubMed ID: 19922610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192.
    Aggarwal G; Prajapati R; Tripathy RK; Bajaj P; Iyengar AR; Sangamwar AT; Pande AH
    PLoS One; 2016; 11(2):e0147999. PubMed ID: 26829396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds.
    Furlong CE
    J Biochem Mol Toxicol; 2007; 21(4):197-205. PubMed ID: 17936934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning.
    Rochu D; Chabrière E; Masson P
    Toxicology; 2007 Apr; 233(1-3):47-59. PubMed ID: 17007987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interethnic variability of plasma paraoxonase (PON1) activity towards organophosphates and PON1 polymorphisms among Asian populations--a short review.
    Mohamed Ali S; Chia SE
    Ind Health; 2008 Aug; 46(4):309-17. PubMed ID: 18716378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human PON1, a biomarker of risk of disease and exposure.
    Furlong CE; Suzuki SM; Stevens RC; Marsillach J; Richter RJ; Jarvik GP; Checkoway H; Samii A; Costa LG; Griffith A; Roberts JW; Yearout D; Zabetian CP
    Chem Biol Interact; 2010 Sep; 187(1-3):355-61. PubMed ID: 20338154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
    Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
    Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase.
    Amitai G; Gaidukov L; Adani R; Yishay S; Yacov G; Kushnir M; Teitlboim S; Lindenbaum M; Bel P; Khersonsky O; Tawfik DS; Meshulam H
    FEBS J; 2006 May; 273(9):1906-19. PubMed ID: 16640555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethylene glycosylation prolongs the stability of recombinant human paraoxonase-1.
    Tiegang L; Nana W; Heng D; Min Z
    Toxicol Lett; 2012 May; 210(3):366-71. PubMed ID: 22414384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro efficacy of paraoxonase 1 from multiple sources against various organophosphates.
    Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Farag HA; Agrawal P; Doctor BP; Nambiar MP
    Toxicol In Vitro; 2011 Jun; 25(4):905-13. PubMed ID: 21382471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Human Paraoxonase 1 the Saviour Against the Persistent Threat of Organophosphorus Nerve Agents?
    Iyengar ARS; Pande AH
    Protein Pept Lett; 2019; 26(7):471-478. PubMed ID: 30942142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.